INTRODUCTION
============

Atherosclerosis produces atheromatous or fibrous fatty plaques that may detach from the vessel walls, thereby blocking the blood vessel and causing ischemic heart disease or cerebrovascular disease \[[@b1-kjfm-17-0098],[@b2-kjfm-17-0098]\]. Calcium deposits can be observed in most cases of advanced atheroma. In other words, vascular calcification implies either advanced atherosclerosis or subclinical cardiovascular disease \[[@b3-kjfm-17-0098],[@b4-kjfm-17-0098]\]. Abdominal aorta calcification (AAC) and calcification of the coronary arteries and aortic arch are considered markers of subclinical atherosclerotic disease that are independent predictors of subsequent vascular morbidity and mortality \[[@b5-kjfm-17-0098]\]. Wilson et al. \[[@b6-kjfm-17-0098]\] measured the amount of calcification of the abdominal aorta using lumbar radiography and reported that AAC was a marker of subclinical atherosclerotic disease and an independent predictor of subsequent vascular morbidity and mortality. Another study used multidetector-row computed tomography (CT) to quantify the calcification of the abdominal aorta and common iliac artery and found that the calcification level was associated with not only smoking history but also high blood pressure, diabetes, chronic kidney disease, and coronary artery disease \[[@b7-kjfm-17-0098]\]. Lehmann et al. \[[@b8-kjfm-17-0098]\] found that middle-aged men who smoke developed coronary artery calcification 10 years earlier than never-smokers. This time span was 8 years in middle-aged women who smoke.

Regular or chronic smoking increases the heart rate and blood pressure, reflecting persistent stimulation of the sympathetic nervous system. Smoking-induced oxidative stress also contributes to several mechanisms of cardiovascular disease, including inflammation, endothelial dysfunction, and lipid abnormalities (e.g., oxidation of low-density lipoprotein and platelet activation \[[@b9-kjfm-17-0098]\]. Radiologic studies on the association of smoking with vascular calcification have shown that smoking for a high number of pack-years contributes to coronary artery and aortic calcium deposition and that middle-aged men who smoke develop coronary artery calcification 10 years earlier than never-smokers \[[@b8-kjfm-17-0098],[@b10-kjfm-17-0098]\]. These studies focused mainly on coronary artery or thoracic aortic calcification.

Abdominal CT is commonly used in the clinical setting. AAC is usually asymptomatic and commonly detected on CT even in healthy people, because this modality is the most sensitive tool with which to identify vascular calcification. Lesion-focused CT tends to result in overlooking AAC in the clinical setting. It is necessary to assess potent risk factors associated with atherosclerosis, including smoking-related factors such as smoking duration (years), amount, and status and incidental AAC during health check-ups. This study examined the association between smoking and AAC detected by CT in asymptomatic Korean middle-aged and elderly men.

METHODS
=======

1. Study Subjects
-----------------

Among 13,432 patients who visited the health promotion center of Chungnam National University Hospital in Daejeon between January 1, 2009, and December 31, 2010. We screened 238 men aged 40 to 81 years who underwent health check-ups that included abdominal CT. Of these, 20 patients with missing data on lifestyle factors were excluded. In other words, the exclusion criteria were as follows: nonperformance of abdominal CT, female sex, cardiovascular disease history, or missing data. Ultimately, 218 patients were enrolled, and their medical records and abdominal CT results were retrospectively reviewed. This study was approved by the Institutional Review Board of National University Hospital (IRB approval no., 2015-12-015). Informed consent was waived.

2. Data Collection
------------------

Data on all patients were collected from health check-up records. Factors that were considered to be associated with atherosclerosis, including age, body mass index (BMI), waist circumference, systolic blood pressure (SBP) and diastolic blood pressure (DBP), total cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), were abstracted for the data analysis,. The patients were divided into three smoking categories as recommended by the US Centers for Disease Control and Prevention: \[[@b11-kjfm-17-0098]\] current, former, and never-smokers.

Patients who reported smoking at least 100 cigarettes in their lifetime and, at the time of the survey, smoked either every day or on some days were defined as current smokers. Patients who reported smoking at least 100 cigarettes in their lifetime and, at the time of the survey, did not smoke at all were classified as former smokers. Patients who reported never having smoked 100 cigarettes were classified as never-smokers. The exercise status of the patients was classified using the American Heart Association recommendations: \[[@b12-kjfm-17-0098]\] those who did not exercise (no exercise group), those who exercised less than three times per week (irregular exercise group), and those who exercised three times or more per week for at least 30 minutes per session (regular exercise group). The weekly amount of alcohol consumed was calculated from the drinking frequency per week and drinks per day. To adjust for chronic medical diseases in the analysis, diabetes, hypertension, and dyslipidemia were assessed. SBP and DBP were measured in the sitting position using an automatic sphygmomanometer (BP-203 RV III; OMRON Matsusaka Co. Ltd., Matsusaka, Japan). Patients were identified as having hypertension if they were taking antihypertensive drugs or had a measured SBP of ≥140 mm Hg or DBP of ≥90 mm Hg. We defined diabetes as a fasting blood sugar level of ≥126 mg/dL or the use of antidiabetic medication. Dyslipidemia was defined as receiving treatments for dyslipidemia based on the recommendation of National Cholesterol Education Program's Adult Treatment Panel III guideline for LDL or a total cholesterol level ≥240 mg/dL or TG level ≥150 mg/dL.

3. Abdominal Aorta Calcification Measurement
--------------------------------------------

To evaluate the level of AAC and common iliac artery calcification, multidetector row CT (Brilliance 64; Philips, Amsterdam, The Netherlands) images were analyzed. The overall severity of calcification was graded semiquantitatively using a 5-point scale \[[@b13-kjfm-17-0098]\], ranging from absent or minimal calcifications to severe diffuse calcifications using the following criteria: (1) grade 1, either (a) no arterial calcifications; (2) grade 2, mild noncircumferential noncontiguous arterial calcifications involving numerous segments with \<50% involvement of individual segments; (3) grade 3, moderate noncircumferential noncontiguous calcifications of multiple arterial segments with \>50% calcification of multiple segments; (4) grade 4, moderate calcifications involving multiple segments of arteries with most areas having \>50% involvement with calcification and the presence or absence of isolated completely concentric calcifications; and (5) grade 5, diffuse calcifications with multiple levels of completely concentric calcifications.

A single physician assessed the lesions to avoid individual bias. We divided the patients into two groups, those with no calcification (grade 1) and those with calcification (grades 2--5), because the frequencies of grades 3 to 5 were too small to evaluate the relationship between AAC and smoking-related variables.

4. Statistical Analysis
-----------------------

We compared the characteristics of the patients according to the smoking status. The chi-square test was used to compare categorical variables, and one-way analysis of variance with Scheffe's post hoc test was used to compare age; BMI; waist circumference; SBP; DBP; total cholesterol, HDL-C, LDL-C, and TG levels; exercise time; and weekly drinking quantity. The percentages of patients with diabetes, hypertension, dyslipidemia, and AAC among the three groups were compared using the chi-square test. Logistic regression analysis, adjusting for confounding variables, was used to assess the effects of smoking-related factors on AAC. All statistical analyses were conducted using IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA). The level of statistical significance was set at P-value \<0.05.

RESULTS
=======

1. General Characteristics of the Patients
------------------------------------------

The average age of former smokers was significantly higher than that of never-smokers and current smokers (P\<0.05). However, there was no significant difference in BMI, waist circumference, HDL-C level, SBP, or DBP among the three groups. Total cholesterol and LDL-C levels of current smokers were significantly lower than those in never-smokers and former smokers (P\<0.05). TG levels were lower in former smokers than those in never-smokers and current smokers (P\<0.01). The weekly exercise frequency was lower in current smokers than that in never-smokers and former smokers (P\<0.01), and the exercise pattern showed a different distribution among the three groups (P\<0.01). With respect to medical diseases that might affect atherosclerosis, there were no significant differences in the proportion of patients with hypertension. The proportion of patients with diabetes and dyslipidemia was significantly different among the three groups (P\<0.01). AAC was found in 37.6% of the study sample ([Table 1](#t1-kjfm-17-0098){ref-type="table"}).

2. Smoking and Abdominal Aorta Calcification
--------------------------------------------

There were significant differences in the distribution of AAC according to all smoking-related variables, including smoking status, smoking duration (years), daily smoking amount (packs/d), and overall smoking amount (pack-years). The percentages of patients with AAC among never-smokers, former smokers, and current smokers were 22.3%, 44.4%, and 52.9%, respectively (P\<0.001). With respect to smoking duration (years), the percentage of patients with AAC among those who had smoked for ≥20 years was 57.8%, which was significant different from the percentages among never-smokers and those who had smoked for \<20 years (P\<0.001). With respect to the daily smoking amount, the proportion of patients with AAC was significantly different among the groups (never-smokers, 22.3%; \<0.5 pack/d, 36.6%; 0.5--1 pack/d, 54.4%; and \>1 pack/d, 60.0%; P\<0.001). The proportion of patients with AAC was also significantly different according to the smoking amount (pack-years) (P\<0.001) ([Table 2](#t2-kjfm-17-0098){ref-type="table"}).

3. Odds Ratio of Abdominal Aorta Calcification Based on Smoking Characteristics
-------------------------------------------------------------------------------

To evaluate the factors associated with AAC, we performed logistic regression analyses adjusting for confounding variables such as age; exercise; waist circumference; SBP, DBP, HDL-C, LDL-C, and TG levels; diabetes; hypertension; and dyslipidemia. Regarding the smoking period, smoking for ≥20 years compared with never smoking was associated with an increased adjusted odds ratio (AOR) of having AAC (AOR, 5.22; 95% confidence interval \[CI\], 1.82--14.93). Other smoking-related variables associated with AAC were 10+ pack-years of smoking (10--20 pack-years: AOR, 4.54; 95% CI, 1.47--14.03; \>20 pack-years: AOR, 5.28; 95% CI, 2.10--13.31), smoking history (former smoker: AOR, 2.10; 95% CI, 1.07--5.68; current smoker: AOR, 5.05; 95% CI, 2.08--12.26), daily smoking amount (\<0.5 pack/d: AOR, 3.41; 95% CI, 1.15--10.11; 0.5--1 pack/d: AOR, 3.74; 95% CI, 1.51--9.29; \>1 pack/d: AOR, 6.11; 95% CI, 1.50--24.93) ([Table 3](#t3-kjfm-17-0098){ref-type="table"}).

DISCUSSION
==========

This study found an association between cigarette smoking and AAC among Korean middle-aged and elderly men. Smoking for more than 20 years, former or current smoking, smoking for 10+ pack-years, and even light smoking increased the odds of AAC. Cardiovascular disease develops 2 to 4 times more often in smokers \[[@b8-kjfm-17-0098],[@b14-kjfm-17-0098]\], and the risk of peripheral arterial disease is markedly elevated in smokers \[[@b15-kjfm-17-0098]\]. In this study, the AOR of AAC for current smokers was 5.0, which is in line with those in previous studies \[[@b10-kjfm-17-0098]\]. The AOR of AAC for former smokers was 2.1, which supports the finding that the risk of coronary heart disease is less than half of that in continuing smokers \[[@b11-kjfm-17-0098]\]. Additionally, although there is no statistical significance, the risk for AAC increased by 80% or more in less than 20 pack-years and 49% in less than 10 pack-years. It suggested that further studies are needed to prove that small amount and short duration of smoking have negative vascular effects such as atherosclerosis.

In particular, smoking for more than 20 years increased the risk of having AAC. Until now, no study has reported a cutoff period at which smoking increases the odds of AAC. However, our results are acceptable when the following points are considered. First, most Korean smokers started smoking in their late teens or early twenties; therefore, those who have smoked for more than 20 years would be in their late thirties or older \[[@b16-kjfm-17-0098]\]. The prevalence of metabolic syndrome, which can exacerbate atherosclerosis, begins to increase in this age group \[[@b17-kjfm-17-0098]\]. Second, atherosclerosis is a sign of aging that progresses slowly for a long period of time \[[@b1-kjfm-17-0098],[@b18-kjfm-17-0098]\], smoking is a potent factor that promotes atherosclerosis \[[@b14-kjfm-17-0098],[@b15-kjfm-17-0098],[@b19-kjfm-17-0098]\], and vascular calcification such as that in the abdominal aorta \[[@b15-kjfm-17-0098]\]. Although autopsy studies have found more extensive atherosclerotic changes in young adults, vascular calcification tends to be detected later radiologically than pathologically \[[@b20-kjfm-17-0098],[@b21-kjfm-17-0098]\]. Therefore, our findings suggest that clinicians should provide intensive counseling to middle-aged and older patients engaged in longer-term or active smoking regarding smoking and health issues, including AAC, to prevent cardiovascular complications.

An increased number of pack-years tended to increase the AOR of AAC markedly (10--20 years: AOR, 4.54; \>20 years: AOR, 5.28). A study targeting middle aged Japanese and Korean found that OR of aortic calcification for smokers with higher pack-years were 3.6 in Koreans \[[@b10-kjfm-17-0098]\]. The AOR in our study was higher than that. This may be because the average age of the patients in our study was older (\>55 years), indicating that smoking at an older age may have a synergic effect with other cardiovascular risk factors. Although the two studies differed in their design and methods, the difference in the AOR between the two studies supports the benefits of early smoking cessation.

With respect to the daily smoking amount, the risk of AAC increased with the number of packs smoked per day, starting at \<0.5 pack/d. The daily smoking amount and pack-years were associated with AAC or coronary artery calcification, which also concurs with previous studies \[[@b15-kjfm-17-0098],[@b22-kjfm-17-0098]\]. These studies showed that smoking is a potent risk factor for developing cardiovascular and peripheral artery diseases. Additionally, the risk associated with smoking was striking and increased with the number of cigarettes smoked per day and number of years of smoking \[[@b23-kjfm-17-0098],[@b24-kjfm-17-0098]\]. Accordingly, physicians should emphasize absolute abstinence from smoking, rather than light or moderate smoking, to their patients. Even when a patient's chief complaint is not associated with cardiovascular symptoms, smoking cessation is advised, because continued smoking may increase the likelihood of cardiovascular events.

There are some limitations to our study. First, this was a cross-sectional study and thus precludes causal associations of AAC with lifestyle factors and medical diseases. Second, this study targeted only Korean men, and all patients in this study were Korean men and has higher smoking rate than the general population. According to the 2013 Korea National Health and Nutrition Examination Survey \[[@b25-kjfm-17-0098]\], the smoking rates among Korean women (5.4%) were too low to evaluate any relationship between smoking and AAC. Third, we did not evaluate family history of cardiovascular disease and nutrition and which are potential factor in cardiovascular disease, and socioeconomic factors such as income and education were also not assessed. Fourth, we conducted this study only based on the questionnaire that is easily underreported to assess smoking status and amount of participants. Fifth, selection bias exists in this study because we were confined to only male subjects with abdominal CT data. Finally, semiquantitative measurement used to assess AAC was also a major limitation in this study.

Despite these limitations, this study showed that the presence of AAC detected by CT was associated with not only the smoking amount, including the daily amount and pack-years, but also smoking for ≥20 years. Considering that the patients in this study were relatively healthy since we excluded patients with a cardiovascular history, it is important for clinicians to assess smoking behavior and emphasize early cessation of smoking for the promotion of health regardless of age, even in asymptomatic and healthy patients.

No potential conflict of interest relevant to this article was reported.

###### 

Characteristics of the patients (n=218)

  Characteristic                                                    Never-smokers (n=94)                              Former smokers (n=54)                                      Current smokers (n=70)
  ----------------------------------------------------------------- ------------------------------------------------- ---------------------------------------------------------- -----------------------------------------------------------
  Age (y)                                                           53.7±10.2                                         58.3±9.3^[\*](#tfn1-kjfm-17-0098){ref-type="table-fn"}^    54.8±9.4
  Body mass index (kg/m^2^)                                         25.4±2.7                                          25.1±2.6                                                   25.3±3.1
  Waist circumference (cm)                                          87.9±8.2                                          87.7±7.5                                                   87.7±8.8
  Exercise pattern^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^                                                                                                                 
   None                                                             24 (25.5)                                         16 (29.6)                                                  23 (32.9)
   Irregular                                                        41 (43.6)                                         15 (27.8)                                                  31 (44.3)
   Regular                                                          29 (30.9)                                         23 (42.6)                                                  16 (22.9)
  Weekly exercise time (min)                                        102.5±95.6                                        113.8±103.8                                                80.0±92.1^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^
  Systolic blood pressure (mm Hg)                                   131.7±13.7                                        130.4±10.9                                                 130.0±16.5
  Diastolic blood pressure (mm Hg)                                  82.9±10.4                                         80.4±9.2                                                   81.7±12.6
  Total cholesterol level (mg/dL)                                   192.7±31.5                                        192.0±25.3                                                 188.2±39.2^[\*](#tfn1-kjfm-17-0098){ref-type="table-fn"}^
  High-density lipoprotein cholesterol level (mg/dL)                47.9±9.9                                          45.4±8.1                                                   46.5±7.9
  Low-density lipoprotein cholesterol level (mg/dL)                 111.7±27.8                                        113.4±21.7                                                 107.4±32.6^[\*](#tfn1-kjfm-17-0098){ref-type="table-fn"}^
  Triglyceride level (mg/dL)                                        167.1±106.3                                       141.2±65.0^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^   178.4±132.7
  Drinks/wk                                                         5.9±4.7                                           6.6±12.5                                                   7.3±8.6
  Diabetes mellitus^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^   13 (13.8)                                         16 (29.6)                                                  17 (24.3)
  Hypertension                                                      43 (45.7)                                         28 (51.9)                                                  34 (48.6)
  Dyslipidemia^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^        33 (35.1)                                         27 (50.0)                                                  36 (51.4)
  Smoking duration (y)                                              0^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^   14.3±9.9                                                   27.1±10.5
  Amount smoked daily (packs/d)                                     0^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^   0.8±0.4                                                    0.9±0.5
  Amount smoked (pack-years)                                        0^[†](#tfn2-kjfm-17-0098){ref-type="table-fn"}^   0.9±0.5                                                    24.4±6.25

Values are presented as mean±standard deviation or number (%). Diabetes mellitus: fasting blood sugar level of ≥126 mg/dL or the use of antidiabetic medication. Hypertension: hypertension treatments or if the systolic blood pressure was ≥140 mm Hg or diastolic blood pressure was ≥90 mm Hg. Dyslipidemia: treatments for dyslipidemia or the total cholesterol level was ≥240 mg/dL or the TG level was ≥200 mg/dL.

P\<0.05,

P\<0.01 compared with the other groups according to one-way analysis of variance with Scheffe's post hoc test or chi-square test.

###### 

Abdominal aortic calcification according to smoking-related variables in all patients (n=218)

  Smoking variable                                                               Abdominal aortic calcification
  ------------------------------------------------------------------------------ --------------------------------
  Smoking status^[\*](#tfn3-kjfm-17-0098){ref-type="table-fn"}^                  
   Never-smoker                                                                  22.3 (21/94)
   Former smoker                                                                 44.4 (24/54)
   Current smoker                                                                52.9 (37/70)
  Smoking duration (y)^[\*](#tfn3-kjfm-17-0098){ref-type="table-fn"}^            
   Never-smoker                                                                  22.3 (21/94)
   \<20                                                                          26.4 (14/53)
   ≥20                                                                           57.3 (47/71)
  Amount smoked daily (packs/d)^[\*](#tfn3-kjfm-17-0098){ref-type="table-fn"}^   
   Never-smoker                                                                  22.3 (21/94)
   \<0.5                                                                         36.6 (15/41)
   0.5--1                                                                        54.4 (37/68)
   \>1                                                                           60.0 (9/15)
  Smoking amount (pack-years)^[\*](#tfn3-kjfm-17-0098){ref-type="table-fn"}^     
   Never-smoker                                                                  22.3 (21/94)
   \<10                                                                          20.7 (6/29)
   10--20                                                                        38.9 (14/36)
   \>20                                                                          69.5 (41/59)

Values are presented as % (number/total number).

P\<0.001 by chi-square test.

###### 

Logistic regression analysis of abdominal aortic calcification according to smoking-related variables (n=218)

  Smoking variable                 Adjusted odds ratio^[\*](#tfn4-kjfm-17-0098){ref-type="table-fn"}^ (95% confidence interval)
  -------------------------------- ----------------------------------------------------------------------------------------------
  Smoking status                   
   Never-smoker                    1.00
   Former smoker                   2.10 (1.07--5.68)
   Current smoker                  5.05 (2.08--12.26)
  Smoking duration (y)             
   Never-smoker                    1.00
   \<10                            1.81 (0.30--10.95)
   10 to \<20                      1.95 (0.67--5.81)
   ≥20                             5.22 (1.82--14.93)
  Smoking amount (pack-years)      
   Never-smoker                    1.00
   \<10                            1.49 (0.41--5.37)
   10--20                          4.54 (1.47--14.03)
   \>20                            5.28 (2.10--13.31)
  Daily smoking amount (packs/d)   
   Never-smoker                    1.00
   \<0.5                           3.41 (1.15--10.11)
   0.5--1                          3.74 (1.51--9.29)
   \>1                             6.11 (1.50--24.93)

Adjusted for age, exercise, waist circumference, hypertension, dyslipidemia, and diabetes.
